Amphastar Pharmaceuticals (AMPH) Curent Deferred Tax Liability (2014 - 2015)

Amphastar Pharmaceuticals' Curent Deferred Tax Liability history runs 2 years deep, the most recent figure standing at $161000.0 for Q3 2015.

• On a quarterly basis, Curent Deferred Tax Liability fell 79.8% year-over-year to $161000.0 in Q3 2015; TTM through Sep 2015 was $161000.0, a 79.8% decrease from a year earlier, with the FY2014 full-year figure at $1.2 million, changed N/A from the prior year.
• Curent Deferred Tax Liability grew to $161000.0 in Q3 2015 per AMPH's latest filing, from $159000.0 in the prior quarter.
• Across five years, Curent Deferred Tax Liability topped out at $1.2 million in Q4 2014 and bottomed at $156000.0 in Q1 2015.